Evidence map›Paper›PMID 38914974›Full record

ArticleBMC primary care2024

Store-and-forward teledermatology in a Spanish health area significantly increases access to dermatology expertise.

Elena Sánchez-Martín, Isabel Moreno-Sánchez, Marta Morán-Sánchez, Miguel Pérez-Martín, Manuel Martín-Morales, Luis García-Ortiz

Registry-linked trialAbstract read
In one paragraph

Article in BMC primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05625295 (Evaluation of the Implementation of Tele-dermatology, in Its Modality of Non-presential Inter-consultation, in the Province of Salamanca.), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05625295 completednot on this map

Evaluation of the Implementation of Tele-dermatology, in Its Modality of Non-presential Inter-consultation, in the Province of Salamanca.

Typeobservational_patient_registrySponsorFundacion para la Investigacion y Formacion en Ciencias de la SaludRan2022 to 2023Enrolled1,000ConditionsTeledermatology, Primary CareArmsdata collection protocol in clinical history
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Patterns and trends in melanoma mortality in Spain (1999-2022).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena Sánchez-MartínCentro de salud La Alamedilla, Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia Regional de salud de Castilla y León (SACyL), Avenida de Comuneros 27-31, Salamanca, 37003, Spain. esanchezma@saludcastillayleon.es.
Isabel Moreno-SánchezCentro de salud La Alamedilla, Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia Regional de salud de Castilla y León (SACyL), Avenida de Comuneros 27-31, Salamanca, 37003, Spain.
Marta Morán-SánchezServicio de Pediatría, Hospital La Paz, P.º de la Castellana, 261, Madrid, 28046, España.
Miguel Pérez-MartínCentro de salud La Alamedilla, Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia Regional de salud de Castilla y León (SACyL), Avenida de Comuneros 27-31, Salamanca, 37003, Spain.
Manuel Martín-MoralesCentro de salud La Alamedilla, Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia Regional de salud de Castilla y León (SACyL), Avenida de Comuneros 27-31, Salamanca, 37003, Spain.
Luis García-OrtizCentro de salud La Alamedilla, Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia Regional de salud de Castilla y León (SACyL), Avenida de Comuneros 27-31, Salamanca, 37003, Spain.

Funding

Fundacion Vicente y Garcia Corselas de la Universidad de Salamanca GC2022
6 · The paper itself

Abstract

introductionTeledermatology is the practice of dermatology through communication technologies. The aim of this study is to analyze its implementation in a Spanish health area during its first two years.

methodsCross-sectional descriptive study. It included interconsultations between dermatologists and family physicians in the Salamanca Health Area (Spain) after the implementation of the non-face-to-face modality over a period of two consecutive years. A total of 25,424 consultations were performed (20,912 face-to-face and 4,512 non-face-to-face); 1000 were selected by random sampling, half of each modality. MAIN MEASURES: referral rate, response time and resolution time, type of pathology, diagnostic concordance, and quality of consultation.

resultsThe annual referral rate was 42.9/1000 inhabitants (35.3 face-to-face and 7.6 non-face- to-face). The rate of face-to-face referrals was higher in urban areas (37.1) and the rate of non- face-to-face referrals in rural areas (10.4). The response time for non-face-to-face consultations was 2.4 ± 12.7 days and 56 ± 34.8 days for face-to-face consultations (p < 0.001). The resolution rate for non-face-to-face consultations was 44%. Diagnostic concordance, assessed by the kappa index, was 0.527 for face-to-face consultations and 0.564 for non-face-to-face consultations. Greater compliance with the quality criteria in the non-attendance consultations.

conclusionsTeledermatology appears to be an efficient tool in the resolution of dermatological problems, with a rapid, effective, and higher quality response for attention to skin pathologies. REGISTRY: ClinicalTrials.gov Identifier: NCT05625295. Registered on 21 November 2022 ( https://clinicaltrials.gov/ct2/show/ NCT05625295).

Indexed as

DermatologyReferral and ConsultationSkin DiseasesTelemedicineAdolescentAdultAgedChildCross-Sectional StudiesFemaleHealth Services AccessibilityHumansMaleMiddle AgedRemote ConsultationSpainDermatologyPrimary careSkin diseasesTeledermatologyTelemedicine

Identifiers

PMID38914974
PMCPMC11197177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.